We suggest that β-eudesmol and (3R,6R,7S)-1,10-bisaboladien-3-ol in the PWS exhibiting the inhibitory effect to TNF and MMP9, could be a potential mechanism for ameliorating IBD. Here, MMP9 is linked to inflammatory bowel disease.